Lantheus Medical Imaging, Inc. to Present at Jefferies 2010 Global Life Sciences Conference
N. BILLERICA, Mass. (June 3, 2010) – Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic medical imaging, today announced that Don Kiepert, President and Chief Executive Officer, will present at the upcoming Jefferies Global Life Sciences Conference in New York, New York at 9:30 a.m. Eastern Time on Wednesday, June 9, 2010. Mr. Kiepert will provide an overview of the company, its products and its pipeline of diagnostic medical imaging candidates.
The presentation will be webcast live at http://www.wsw.com/webcast/jeff46/lanthe/. The webcast will also be available on the Lantheus Medical Imaging website at www.lantheus.com.
About Lantheus Medical Imaging, Inc.
Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic medicine for more than 50 years, is dedicated to creating and providing pioneering medical imaging solutions to improve the treatment of human disease. The company’s proven success in discovering, developing and marketing innovative medical imaging agents provides a strong platform from which to bring forward breakthrough new tools for the diagnosis and management of disease. Lantheus imaging products include the echocardiography contrast agent DEFINITY® Vial for (Perflutren Lipid Microsphere) Injectable Suspension, ABLAVAR® (gadofosveset trisodium), a first-in-class magnetic resonance agent indicated for the evaluation of aortoiliac occlusive disease in adults with known or suspected peripheral vascular disease, TechneLite® (Technetium Tc99m Generator), Cardiolite® (Kit for the Preparation of Technetium Tc99m Sestamibi for Injection), and Thallium 201 (Thallous Chloride Tl 201 Injection). Lantheus has more than 600 employees worldwide with headquarters in North Billerica, Massachusetts, and offices in Puerto Rico, Canada and Australia. For more information, visit www.lantheus.com.